Estroclic: Birth Control Pill
By BeeDazl
Estroclic is a pill-reminder and pack-tracking app for hormonal contraceptive users on iOS and Android.
The App DNA
What makes this app unique?
It removes the cognitive friction of tracking complex pill regimens without the noise of fertility or pregnancy-related content.
For Individuals using hormonal contraceptive pills who require a dedicated, non-fertility-focused tracking tool for their specific medication schedule.
What does it look like?
Key features
Dedicated tracking logic for combined, traditional progestin-only, desogestrel, and 84-day extended-cycle pills.
Main daily reminder with two automated follow-up alerts at 30 and 60 minutes if the pill is not logged.
Advanced timing analysis, symptom trends, and formatted PDF history reports for clinical discussions.
How much does it cost?
The freemium model gates clinical-grade reporting and symptom trends behind a subscription, while keeping core adherence tools free.
Velocity
Maintenance developmentUX improvementsmonetizationShow more...
The app maintains a maintenance-level cadence, shipping only two updates over the last 38 days. Development is currently focused on minor feature adjustments and accessibility, with the latest release expanding the availability of placebo reminders to all plans. The release frequency remains low, indicating a stable but slow development cycle without frequent feature iteration or live-service events.
Who built it?
BeeDazl
2 apps tracked · Health & Fitness
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Estroclic: Birth Control Pill
How's the Health & Fitness market?
Estroclic operates in the Health & Fitness category, maintaining a focused utility model that avoids the fertility-prediction market. The current release cadence (avg 37 days between updates) suggests a maintenance-heavy posture rather than aggressive chart-climbing.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Estroclic: Birth Control Pill
Where is it heading?
The contraceptive tracking market is consolidating around apps that offer both adherence tools and broader health context. Estroclic's current maintenance-heavy posture limits its ability to compete with rivals that integrate symptom trends and clinical reports into the free tier.
- The latest release (v1.1.5) expanded placebo reminders to all users, signaling a focus on feature parity over new revenue-generating capabilities.
- A 37-day average update cadence indicates a maintenance-mode posture, which leaves the app vulnerable to faster-moving competitors in the Health & Fitness space.
The SWOT
- Medication-specific tracking logic reduces setup friction
- Privacy-first design excludes fertility-prediction noise
- Localized pill-brand databases for international markets
Next best moves
Audit premium tier value because current $6.99/month price point exceeds category median → increase conversion
The counter-intuitive read
The lack of fertility predictions is a retention risk, not just a differentiator…
Read the full takeBottom line
Estroclic defends its niche through medication-specific tracking logic, but the current premium pricing tier requires a larger feature set to justify the cost against free, ad-supported alternatives.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated